BIOC fundamentals
GLAXO SMITH KLINE financial statements, including revenue, expenses, and profit
The annual and quarterly earnings report below will help you understand the performance of BIOC.
Q4 '14
Q1 '15
Q2 '15
Q3 '15
Q4 '15
Q1 '16
Q2 '16
Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−250.00 M
0.00
250.00 M
500.00 M
750.00 M
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EGP
Q4 '14
Dec 2014
Q1 '15
Mar 2015
Q2 '15
Jun 2015
Q3 '15
Sep 2015
Q4 '15
Dec 2015
Q1 '16
Mar 2016
Q2 '16
Jun 2016
Q3 '16
Sep 2016
Q4 '16
Dec 2016
Q1 '17
Mar 2017
Q2 '17
Jun 2017
Q3 '17
Sep 2017
Q4 '17
Dec 2017
Q1 '18
Mar 2018
Q3 '18
Sep 2018
Q4 '18
Dec 2018
Q1 '19
Mar 2019
Q2 '19
Jun 2019
Q3 '19
Sep 2019
Q1 '20
Mar 2020
Q1 '21
Mar 2021
Q2 '21
Jun 2021
Q3 '21
Sep 2021
Q1 '22
Mar 2022
Q2 '22
Jun 2022
Q1 '23
Mar 2023
Q2 '23
Jun 2023
Q3 '23
Sep 2023
Q1 '24
Mar 2024
Q2 '24
Jun 2024
Q3 '24
Sep 2024
Q4 '24
Dec 2024
TTM
Total revenueYoY growth
346.60 M
+9.28%
460.66 M
+1.14%
539.66 M
+31.37%
576.44 M
+53.42%
713.81 M
+105.94%
—
—
—
—
Gross profitYoY growth
94.05 M
−34.83%
109.63 M
−19.47%
113.83 M
−35.19%
169.71 M
+54.70%
325.64 M
+246.25%
—
—
—
—
Operating incomeYoY growth
−3.86 M
−111.03%
34.98 M
+9.25%
9.16 M
−83.15%
105.17 M
+100.14%
76.32 M
—
—
—
—
—
Pretax incomeYoY growth
13.79 M
+212.81%
21.57 M
+12.56%
7.03 M
−85.32%
47.53 M
+160.89%
4.94 M
−64.20%
—
—
—
—
Net incomeYoY growth
2.64 M
−1.98%
13.81 M
−23.05%
5.76 M
−88.23%
27.16 M
−46.92%
−8.99 M
−440.07%
—
—
—
—
2.64 M
13.81 M
5.76 M
27.16 M
−8.99 M
—
—
—
—
Basic earnings per share (Basic EPS)YoY growth
0.03
−1.86%
0.17
−23.03%
0.07
−88.23%
0.33
−46.91%
−0.11
−439.43%
—
—
—
—
Diluted earnings per share (Diluted EPS)YoY growth
0.03
−1.86%
0.17
−23.03%
0.07
−88.23%
0.33
−46.91%
−0.11
−439.43%
—
—
—
—
EBITDAYoY growth
8.10 M
−82.92%
46.82 M
−1.43%
20.96 M
−70.38%
117.12 M
+76.98%
89.04 M
+998.68%
—
—
—
—
EBITYoY growth
−3.86 M
−111.03%
34.98 M
+9.25%
9.16 M
−83.15%
105.17 M
+100.14%
76.32 M
—
—
—
—
—